Core Scientific (CORZR) Accounts Payables (2021 - 2026)

Core Scientific's Accounts Payables history runs 6 years deep, the most recent figure standing at $218.9 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 3358.55% year-over-year to $218.9 million; the TTM figure through Mar 2026 stood at $218.9 million (up 3358.55% YoY), while the FY2025 annual figure was $126.1 million, up 554.59% from the prior year.
• Accounts Payables came in at $218.9 million for Q1 2026 at Core Scientific, up from $126.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $218.9 million in Q1 2026 to a low of $6.3 million in Q1 2025.
• A 5-year average of $75.2 million and a median of $45.5 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables soared 18028.55% in 2022 and plunged 87.55% in 2024, its largest moves.
• Core Scientific's Accounts Payables stood at $53.6 million in 2022, then soared by 188.49% to $154.8 million in 2023, then slumped by 87.55% to $19.3 million in 2024, then soared by 554.59% to $126.1 million in 2025, then jumped by 73.55% to $218.9 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $218.9 million, $126.1 million, and $212.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison